How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to the consensus estimate of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%. During the same quarter last year, the company posted $0.13 earnings per share.

What is J. Patrick Mackin's approval rating as CryoLife's CEO?

53 employees have rated CryoLife Chief Executive Officer J. Patrick Mackin on Glassdoor.com . J. Patrick Mackin has an approval rating of 81% among the company's employees.

What other stocks do shareholders of CryoLife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoLife investors own include Energy Transfer (ET) , AT&T (T) , NVIDIA (NVDA) , Teva Pharmaceutical Industries (TEVA) , Enterprise Products Partners (EPD) , Gilead Sciences (GILD) , Netflix (NFLX) , Zoetis (ZTS) , Ares Capital (ARCC) and Edwards Lifesciences (EW) .

Does CryoLife have any subsidiaries?

The following companies are subsidiares of CryoLife: AuraZyme Pharmaceuticals Inc., Cardiogenesis Corporation, CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., CryoLife Europa Ltd., CryoLife France SAS., CryoLife Germany HoldCo GmbH, CryoLife Germany TopCo GmbH, CryoLife International Inc., Hemosphere, JOTEC AG, JOTEC Cardiovascular S.L., JOTEC Polska Sp. z.o.o, JOTEC Sales GmbH, JOTEC UK Ltd., JOTEC do Brasil, JOTEC s.r.l., Jolly Buyer Acquisition GmbH, Jotec, On-X Life Technologies Holdings Inc., On-X Life Technologies Inc., and Valve Special Purpose Co. LLC. Read More

NYSE:CRY

CryoLife (CRY) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free CRY Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $17.19
▼
$21.72
52-Week Range: N/A

Volume: 7,792 shs
Average Volume: 198,221 shs
Market Capitalization: $703.22 million

P/E Ratio: 596.20
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get CryoLife alerts:

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About CryoLife Stock (NYSE:CRY)

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

CRY Stock News Headlines

April 8, 2024 | uk.finance.yahoo.com

Global Surgical Sealants and Adhesives Market Analysis Report 2024-2030: A USD 5.39 Billion Market by 2030, with 11.8% Forecasted CAGR

March 9, 2024 | investing.com

Braskem SA Class A (BAK)

April 16, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

February 16, 2024 | markets.businessinsider.com

Artivion Secures Buy Rating: Strong Financials and Growth Trajectory Propel Price Target Increase

February 14, 2024 | markets.businessinsider.com

CryoLife earnings: here's what to expect

February 6, 2024 | finance.yahoo.com

Hemostats Market revenue to exceed USD 5000 Million by 2033, says Research Nester

January 31, 2024 | markets.businessinsider.com

Buy Rating on Artivion’s Stock Backed by Strong PERSEVERE Study Results and Market Potential

January 15, 2024 | finance.yahoo.com

Global Cord Blood & Tissue Banking Industry Report Market Size, Segmentation, & Forecasts, 2024

April 16, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

January 10, 2024 | finance.yahoo.com

Q3 2024 Park Aerospace Corp Earnings Call

December 28, 2023 | seekingalpha.com

Artivion Stock: A First Assessment

December 19, 2023 | finance.yahoo.com

Pediatric Heart Valve Repair and Replacement Market to Witness 2.7% CAGR, Reaching US$ 4,490.5 Million by 2034 | Future Market Insights, Inc.

November 21, 2023 | markets.businessinsider.com

Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

November 1, 2023 | benzinga.com

Bone Cement Market Size, Growth & Statistical Report from 2023 to 2030

October 19, 2023 | finance.yahoo.com

Aortic Stent Grafts Market to Surpass 3.01 Billion by 2030 Drives Due to Medical Advancements

October 3, 2023 | finance.yahoo.com

Global Aortic Stents Grafts Market to Record a CAGR of 5% and Reach US$ 4.2 billion by 2033 | Future Market Insights, Inc.

September 14, 2023 | benzinga.com

Heart Valve Devices Market to be Worth US$ 37.5 Billion by 2033 | Fact.MR Report

August 25, 2023 | finance.yahoo.com

Cardiac Sutures Global Market Report 2023

August 5, 2023 | msn.com

Needham Reiterates Artivion (AORT) Buy Recommendation

July 4, 2023 | finance.yahoo.com

Biosurgery Global Market Report 2023

June 9, 2023 | finance.yahoo.com

Dermatology Lasers Global Market Report 2023

May 21, 2023 | uk.finance.yahoo.com

CryoLife, Inc. (CYL.F)

May 17, 2023 | finance.yahoo.com

Laser Therapy Global Market Report 2023: Increasing Demand from Non-invasive Laser Surgeries Drives Growth

May 17, 2023 | marketwatch.com

Regenerative Medicine Market (2023-2030): Research Report, Growth, Trends and Competitive Analysis

May 17, 2023 | marketwatch.com

Global Tissue Level Implant Market to Witness Significant Growth Due to Increasing Adoption Forecast 2023-2030

May 17, 2023 | marketwatch.com

Global Hemostatic Gel Market [2023-2030] | Growing at a CAGR 5.2% (Expected to Reach 1356.5)

May 16, 2023 | marketwatch.com

Global Organ and Tissue Transplantation and Alternative Market Size 2023-2031 Business Strategies by Absolute Reports | with [94 Pages]

See More Headlines

Receive CRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2021
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & Medical Instruments
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:CRY
CUSIP: 22890310
CIK: 784199
Web: www.cryolife.com
Phone: (770) 419-3355
Fax: 770-426-0031
Employees: 1,200
Year Founded: 1984

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 596.20
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,680,000.00
Net Margins: 0.63%
Pretax Margin: 0.41%
Return on Equity: 4.24%
Return on Assets: 1.63%

Debt

Debt-to-Equity Ratio: 0.99
Current Ratio: 4.21
Quick Ratio: 2.93

Sales & Book Value

Annual Sales: $253.23 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 23.30
Book Value: $8.46 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 39,330,000
Free Float: 37,560,000
Market Cap: $703.22 million
Optionable: Optionable
Beta: 1.53

Social Links

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

James Patrick Mackin
Chairman, President & Chief Executive Officer
David Ashley Lee
Chief Operating & Financial Officer, Executive VP
Scott B. Capps
Vice President-Clinical Research
Franz Peter Barthold
Vice President-Research & Development
Marshall S. Stanton
Chief Medical Officer & SVP-Clinical Research

Key Competitors

View All Competitors

CRY Stock Analysis - Frequently Asked Questions

How were CryoLife's earnings last quarter?: CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to the consensus estimate of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%. During the same quarter last year, the company posted $0.13 earnings per share.
What is J. Patrick Mackin's approval rating as CryoLife's CEO?: 53 employees have rated CryoLife Chief Executive Officer J. Patrick Mackin on Glassdoor.com. J. Patrick Mackin has an approval rating of 81% among the company's employees.
What other stocks do shareholders of CryoLife own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CryoLife investors own include Energy Transfer (ET), AT&T (T), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Netflix (NFLX), Zoetis (ZTS), Ares Capital (ARCC) and Edwards Lifesciences (EW).
Does CryoLife have any subsidiaries?: The following companies are subsidiares of CryoLife: AuraZyme Pharmaceuticals Inc., Cardiogenesis Corporation, CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., CryoLife Europa Ltd., CryoLife France SAS., CryoLife Germany HoldCo GmbH, CryoLife Germany TopCo GmbH, CryoLife International Inc., Hemosphere, JOTEC AG, JOTEC Cardiovascular S.L., JOTEC Polska Sp. z.o.o, JOTEC Sales GmbH, JOTEC UK Ltd., JOTEC do Brasil, JOTEC s.r.l., Jolly Buyer Acquisition GmbH, Jotec, On-X Life Technologies Holdings Inc., On-X Life Technologies Inc., and Valve Special Purpose Co. LLC.
Read More

This page (NYSE:CRY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CryoLife (CRY) Stock Price, News & Analysis

About CryoLife Stock (NYSE:CRY)

CRY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

CRY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info